DrugPatentWatch Database Preview
ADDERALL XR 5 Drug Profile
Which patents cover Adderall Xr 5, and when can generic versions of Adderall Xr 5 launch?
Adderall Xr 5 is a drug marketed by Shire and is included in one NDA. There are four patents protecting this drug.
This drug has ten patent family members in eight countries.
The generic ingredient in ADDERALL XR 5 is amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. There are fifty-five drug master file entries for this compound. Twenty-three suppliers are listed for this compound. Additional details are available on the amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate profile page.
Summary for ADDERALL XR 5
| International Patents: | 10 |
| US Patents: | 4 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 6 |
| Bulk Api Vendors: | 1 |
| Clinical Trials: | 33 |
| Formulation / Manufacturing: | see details |
| DailyMed Link: | ADDERALL XR 5 at DailyMed |
Pharmacology for ADDERALL XR 5
| Drug Class | Central Nervous System Stimulant |
| Physiological Effect | Central Nervous System Stimulation |
US Patents and Regulatory Information for ADDERALL XR 5
International Patents for ADDERALL XR 5
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Austria | 427101 | ➤ Try a Free Trial |
| European Patent Office | 1123087 | ➤ Try a Free Trial |
| World Intellectual Property Organization (WIPO) | 0023055 | ➤ Try a Free Trial |
| Australia | 1214500 | ➤ Try a Free Trial |
| European Patent Office | 1977736 | ➤ Try a Free Trial |
| Germany | 69940673 | ➤ Try a Free Trial |
| Country | Document Number | Estimated Expiration |
